In summary, MLL/COMPASS and PRC2 promote a hypomethylated state, particularly focused on promoters and CGI, while PRC1 promotes DNA hypermethylation; promoters where this interplay occurs are susceptible to aberrant DNA hypermethylation in human cancers. This evidence concerns the gene KMT2A and cancer.